Press Releases: In-Vitro Diagnostics
Select a different year:
Siemens Completes $100 Million Building Expansion at State-of-the-Art Manufacturing Facility
September 8, 2008
Siemens Healthcare (www.siemens.com/healthcare) celebrated completion of a 115,000 square foot facility expansion today at its state-of-the-art manufacturing facility in Walpole, Massachusetts. Siemens Healthcare Diagnostics is the leading clinical diagnostics company in the world, offering the most comprehensive portfolio of products and solutions used to diagnose, treat and monitor patients around the globe. More
Siemens Launches ADVIA 2120i Hematology System
July 22, 2008
DEERFIELD, Ill. July 22, 2008 - Siemens Healthcare (www.siemens.com/diagnostics) launched the ADVIA® 2120i Hematology System, the latest addition to the company’s family of hematology instruments used in the clinical laboratory. The system provides the most current technology for white blood cell differential, red blood cell, reticulocyte, platelet and cerebral spinal fluid testing, benefiting all sizes and types of hematology laboratories, including routine, specialty, University, oncology and research laboratories. This new hematology system has many automation features that save laboratory personnel’s time, allowing laboratories to improve productivity and reduce costs. More
Siemens Receives FDA Approval for HIV-1 Test on Automated Molecular Instrument
July 22, 2008
DEERFIELD, Ill. July 22, 2008 - Siemens Healthcare (www.siemens.com/diagnostics) received approval from the U.S. Food and Drug Administration (FDA) to sell its VERSANT® HIV-1 RNA 3.0 viral load test in the United States, for use on the automated VERSANT® 440 Molecular System. This approval allows clinical laboratories to benefit from running an FDA-approved HIV-1 and hepatitis C virus (HCV) test on one single viral load testing platform. Viral load testing is a quantitative method critical to monitoring a patient’s infection and therapy. More
Siemens Launches New ADVIA CentraLink Informatics Product
July 22, 2008
Deerfield, Ill, July 22, 2008―Siemens Healthcare (www.siemens.com/diagnostics) has launched a new version of the ADVIA CentraLink® informatics product that allows clinical laboratory customers to significantly improve workflow, operational efficiency and management of patient data. This new (version 12) software will help to reduce overall costs in the laboratory and also improve the laboratory’s support of patient care in their facility. It seamlessly connects multiple diagnostic instruments to a laboratory information system (LIS) in a stand-alone or automation configuration. More
Premier Healthcare Alliance Honors Siemens Healthcare Diagnostics for Excellence in Supplier Performance
June 23, 2008
MALVERN, Pa., June 23, 2008 - The Premier healthcare alliance Purchasing Partners division recently announced that Siemens Healthcare Diagnostics (www.siemens.com/diagnostics) was one of 15 winners chosen for the Pinnacle Award out of more than 800 eligible suppliers, representing the top two percent of healthcare equipment suppliers. The award recognizes suppliers whose performance exceeds the expectations of Premier and its members as they carry out their missions of meeting the healthcare needs of communities they serve. This is the third consecutive year Siemens Healthcare Diagnostics has been selected for this award. More
Siemens Healthcare Donates and Implements Critical Medical Equipment to Aid China's Earthquake Zone
May 28, 2008
ERLANGEN, Germany, May 28, 2008 – Siemens Healthcare (www.siemens.com/healthcare) announces the donation and implementation of important medical equipment to the China Red Cross and the Sichuan Provincial Healthcare Bureau, aiding in medical treatment of those affected by the May 12 earthquake that hit the Chinese province of Sichuan. The equipment was quickly routed to the disaster area to assist in the treatment of survivors. The donation of medical equipment follows Siemens EUR 180,000 cash donation and brings Siemens total contribution of aid to the Sichuan earthquake disaster to EUR 540,000. More
Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests
May 8, 2008
DEERFIELD, Ill. May 8, 2008 - Siemens Healthcare and Laboratory Corporation of America® Holdings (LabCorp®) today announced that they have entered a non-exclusive agreement to discuss future possibilities to co-develop new clinical diagnostic tests in the areas of companion diagnostics, metabolic syndrome, oncology and diabetes. Under the agreement, initial discussions will focus on developing new tests that could make the biggest impact to patient care. More
Donal Quinn Heads Diagnostics Division of Siemens Healthcare Sector
May 6, 2008
Erlangen, Germany, May 6, 2008 – Donal Quinn has been appointed new head of the Diagnostics division of the Siemens Healthcare Sector (www.siemens.com/healthcare). In his new position, Quinn succeeds Jim Reid-Anderson, who on May 1 became the new CEO of this sector. Prior to his new job, Quinn served as executive vice president and chief customer officer of the Diagnostics division since November 2007. More
Siemens Launches New Point-of-Care Analyzer for Diabetes Management
March 7, 2008
Siemens Healthcare launches the DCA Vantage™ Analyzer, a point-of-care (POC) diabetes patient management platform reporting glycosylated hemoglobin (HbA1c), microalbumin/creatinine and albumin-to-creatinine results for diabetes management. The DCA Vantage Analyzer is critical for monitoring a patient’s glycemic control and helps physicians to encourage patient compliance by delivering actionable test results during a patient visit. The system delivers the simplicity and convenience required at the point of care with no sample or reagent preparation steps. This analyzer is both CLIA waived and NGSP certified for HbA1C tests. More
Siemens and Customer Sign Five-Year Agreement for Molecular Testing Products
February 22, 2008
Siemens Healthcare Diagnostics has signed a five-year, multi-product agreement with Mayo Clinic to provide molecular testing capabilities that enable screening and early detection of major infectious diseases, monitoring of treatment efficacy, and selection of individualized or clinical research options. Through the agreement, Siemens will provide its VERSANT® and TRUGENE® products for assessment of human immunodeficiency virus (HIV-1), hepatitis B virus (HBV) and hepatitis C virus (HCV) viral load, genotyping, and drug resistance. More
Siemens Receives FDA Approval for the VERSANT 440 Molecular System
February 18, 2008
DEERFIELD, IL., Feb. 18, 2008 ― Siemens Healthcare (www.siemens.com/diagnostics) announced today that its VERSANT™ 440 Molecular System has been approved for marketing by the U.S. Food and Drug Administration (FDA) for use with the VERSANT HCV RNA 3.0 assay for management of HCV-infected patients undergoing antiviral therapy. The VERSANT 440 Molecular System represents the next generation in automated viral load testing, providing laboratories with greater throughput and less hands-on time, maximizing productivity to meet the evolving needs of the clinical laboratory. More
The Dark Report and Siemens Introduce the World's First Integrated Molecular Summit
January 28, 2008
PHILADELPHIA, Pa., JAN. 28, 2008 Recent advances in genetic knowledge are transforming molecular imaging, molecular diagnostics and informatics to create stunningly precise diagnostic tools capable of assessing and treating a growing number of critical diseases. These new diagnostic tools provide physicians with an understanding of individual patient or disease differences at the molecular or genetic level, enabling them to leverage predictive diagnosis and tailor effective treatment to the individual. More
Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on its Dimension Vista Intelligent Lab System
January 16, 2008
Deerfield, IL, January 16, 2008 - Siemens Healthcare Diagnostics, today announced that it has launched the LOCI® Folate, LOCI® B12, and LOCI® Ferritin tests for use on the Dimension Vista® 1500 Intelligent Lab System, an ultra-integrated chemistry analyzer. These tests are used by physicians to diagnose and monitor anemia in patients, and further expand Siemens’ LOCI immunoassay test menu for the Dimension Vista System. More
